Belgium· BE-AMP-SAM107116-00
Amukin 500 mg/2 ml
A amikacin product containing amikacin sulfate, registered in Belgium by Laboratoires Delbert. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Amikacin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Amikacin · ATC J01GB06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Amikacin Sulfate
- Manufacturer
- Laboratoires Delbert
- Country
- Belgium (BE)
- ATC code
- J01GB06
- ATC class
- Amikacin
- Defined daily dose
- 0.59 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
- be_apb0700781
- be_apb7731557
- be_apb0018911
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
253 interactions on record for amikacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amikacin · interactions on record
253 records
- 50 severe
- 133 moderate
- 2 minor
- 68 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amikacin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyAMIKACINA TEVATEVA ITALIA S.R.L.
- SwedenAmikacin Afortas 250 mg/ml Injektionsvätska, lösning2care4 Generics ApS
- FinlandBiklinBristol-Myers Squibb Ab
- SpainAMICACINA BRAUN 500 MG/2ML SOLUCIÓN INYECTABLEB Braun Medical S.A.
- SwitzerlandAmikin
- NorwayAmikacin MacureMacure Pharma ApS
- PolandAmikacin AdamedAdamed Pharma S.A.
- CzechiaAMIKACIN B. BRAUNB. Braun Melsungen AG, Melsungen
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Amikacin B. Braun
- Bulgaria · Amikacin Kabi, Амикацин Б. Браун
- Cyprus · Amika-Synto, Amikacin Vioser
- Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
- Germany · Amikacin B. Braun, Amikacin Eberth
- Denmark · Amikacin Afortas, Amikacin Macure
- Estonia · Amikacin B. Braun
- Spain · Amicacina, Amicacina B. Braun
- Finland · Amikacin Afortas, Amikacin Macure
- France · Amikacine B. Braun, Amikacine Kabi
- United Kingdom (Northern Ireland) · Amikacin Demo Pharma Uk, Amikacin Galvany Pharma
- Greece · Amicasil, Amikacin Anfarm
- Croatia · Amikacin Zentiva
- Hungary · Amikacin Anfarm, Amikacin B. Braun
- Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
- Iceland · Arikayce Liposomal
- Italy · Amicasil, Amikacina B. Braun
- Liechtenstein · Arikayce Liposomal
- Lithuania · Biodacyna
- Luxembourg · Amikacin B. Braun, Amukin
- Latvia · Amikacin B.Braun
- Malta · Amikacin Tillomed Laboratories, Uzix
- Netherlands · Amikacine Hospira
- Norway · Amikacin Afortas, Amikacin Macure
- Poland · Amikacin B. Braun, Amikacin Kabi,
- Portugal · Amicacina Hikma, Amicacina Kabi
- Romania · Amikacin Noridem, Amikacină Atb
- Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
- Slovenia · Amikacin Kabi
- Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f27c1fff-68a8-4c53-8c73-9403b38d8d12 GET /v1/drugs/f27c1fff-68a8-4c53-8c73-9403b38d8d12?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Amukin 500 mg/2 ml",
"name_fr": "Amukin 500 mg/2 ml",
"name_nl": "Amukin 500 mg/2 ml",
"amp_code": "SAM107116-00",
"strengths": [
"250.0000",
"12.2000"
],
"pack_count": 4,
"substances": [
"Amikacin Sulfate",
"Amikacin",
"Sodium Metabisulfite"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Amikacin",
"authorisation_numbers": [
"BE107116"
]
}See everything about amikacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.